You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,034,267


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,034,267
Patent landscape, scope, and claims:
Title: Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
Abstract:The invention provides a pharmaceutical compositions comprising a compound of formula I: wherein, R.sup.1 and R.sup.2 have any of the values defined in the specification; or a salt thereof; and a pharmaceutically acceptable carrier or excipient. The invention also provides a method for the diagnosis or photochemotherapeutic treatment of disorders or abnormalities of external or internal surfaces of the body using such compounds or salts.
Inventor(s): Gierskcky; Karl E. (Oslo, NO), Moan; Johan (Oslo, NO), Peng; Qian (Oslo, NO), Steen; Harald (Oslo, NO), Warloe; Trond (Oslo, NO), Bjorseth; Alf (Oslo, NO)
Assignee: PhotoCure AS (Olso, NO)
Application Number:08/913,257
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Device;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,034,267

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,034,267

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9504948Mar 10, 1995
United Kingdom9525822Dec 18, 1995
PCT Information
PCT FiledMarch 08, 1996PCT Application Number:PCT/GB96/00553
PCT Publication Date:September 19, 1996PCT Publication Number: WO96/28412

International Family Members for US Patent 6,034,267

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0820432 ⤷  Subscribe SPC024/2002 Ireland ⤷  Subscribe
European Patent Office 0820432 ⤷  Subscribe SPC/GB02/038 United Kingdom ⤷  Subscribe
European Patent Office 0820432 ⤷  Subscribe 300176 Netherlands ⤷  Subscribe
European Patent Office 0820432 ⤷  Subscribe 300207 Netherlands ⤷  Subscribe
European Patent Office 0820432 ⤷  Subscribe SPC/GB05/044 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.